Pembrolizumab with pemetrexed and platinum-based chemotherapy for untreated unresectable advanced malignant pleural mesothelioma [ID4044]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: 28 May 2025
Pegargiminase with pemetrexed and cisplatin for untreated advanced malignant pleural mesothelioma [ID1575]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC